Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.
暂无分享,去创建一个
K. Welsh | R. D. du Bois | J. Zieliński | P. Pantelidis | V. Kolek | R M du Bois | V Kolek | M Petrek | P J Foley | D S McGrath | E Puscinska | J Drabek | P A Lympany | P Pantelidis | K I Welsh | J Zielinski | M. Petrek | P. Lympany | E. Puścińska | D. McGrath | P. Foley | J. Drábek | R. du Bois | Patrick Foley | Elzbieta Puscinska | Martin Petrek | Jiri Drabek | P. Lympany | Kenneth I. Welsh | Jan Zielinski | Martin Petřek
[1] G. Hunninghake,et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[2] J. Gerdes,et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. , 1999, European cytokine network.
[3] Y. Ina,et al. HLA and sarcoidosis in the Japanese. , 1989, Chest.
[4] R. Lechler,et al. Disease susceptibility, transplantation and the MHC. , 1995, Immunology today.
[5] M. Barnardo,et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[6] J. Muller-Quernheim. Sarcoidosis: immunopathogenetic concepts and their clinical application , 1998 .
[7] N. Mehra,et al. HLA and sarcoidosis. , 1988, Sarcoidosis.
[8] J. Grunewald,et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. , 1997, American journal of respiratory and critical care medicine.
[9] M. Iannuzzi,et al. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. , 1998, American journal of respiratory and critical care medicine.
[10] Y. Ina,et al. Antigen-presenting capacity in patients with sarcoidosis. , 1990, Chest.
[11] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..
[12] U. Şahin,et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.
[13] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[14] R. D. du Bois,et al. The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis. , 1986, Clinical and experimental immunology.
[15] K. Welsh,et al. Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes. , 1998, Tissue antigens.
[16] K. Welsh,et al. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. , 1999, American journal of respiratory and critical care medicine.
[17] M. Martinetti,et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. , 1995, American journal of respiratory and critical care medicine.
[18] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.